Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Sanwa Kagaku Kenkyusho

Status and phase: Completed; Phase 3

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: Miglitol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00334399

MG1008

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Sex: All

Ages: 20 to 69 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetic patients treated with Biguanide
• Criteria for postprandial plasma glucose and HbA1c are met

Exclusion criteria

• Type 1 diabetes
• Patients treated with other antidiabetic drugs or Insulin

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind